{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:38:09Z","timestamp":1791049089315,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3683,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1111\/j.0022-202x.2005.23925.x","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T12:34:47Z","timestamp":1128083687000},"page":"1045-1052","source":"Crossref","is-referenced-by-count":212,"title":["Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action"],"prefix":"10.1016","volume":"125","author":[{"given":"Chunlei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Richon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhshandra","family":"Talpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1396-0296.2003.01642.x","article-title":"Phototherapy for cutaneous T-cell lymphoma","volume":"16","author":"Baron","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+CD26- subset in the identification of circulating Sezary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0781.2002.02740.x","article-title":"Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: A comparison study","volume":"18","author":"Breuckmann","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcp.10364","article-title":"STAT proteins: From normal control of cellular events to tumorigenesis","volume":"197","author":"Calo","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): Characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","article-title":"Clinical development of histone deacetylase inhibitors as anticancer agents","volume":"45","author":"Drummond","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o97-043","article-title":"Cleavage of poly (ADP-ribose) polymerase: A sensitive parameter to study cell death","volume":"75","author":"Duriez","year":"1997","journal-title":"Biochem Cell Biol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0733-8635(05)70155-8","article-title":"Emerging new therapies for cutaneous T-cell lymphoma","volume":"18","author":"Duvic","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jss.2004.05.004","article-title":"Stat6 (null phenotype) human lymphocytes exhibit increased apoptosis","volume":"122","author":"Galka","year":"2004","journal-title":"J Surg Res"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/excr.1998.4319","article-title":"Transcriptional regulation of the p21 (WAF1\/CIP1) gene","volume":"246","author":"Gartel","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-1759(94)00277-4","article-title":"Microculture tetrazolium assays: A comparison between two new tetrazolium salts, XTT and MTS","volume":"179","author":"Goodwin","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0065","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1084\/jem.154.5.1403","article-title":"Human CTCL and leukemia cell lines produce and respond to T cell growth factor","volume":"154","author":"Gootenberg","year":"1981","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0070","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.0307708100","article-title":"Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1","volume":"101","author":"Gui","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0075","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/sj.onc.1203963","article-title":"Activation of the p21WAF1\/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites","volume":"19","author":"Huang","year":"2000","journal-title":"Oncogene"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0080","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190BCR\/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members","volume":"271","author":"Ilaria","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1749-6632.2001.tb03723.x","article-title":"Apoptosis and cutaneous T cell lymphoma","volume":"941","author":"Kacinski","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0090","first-page":"3578","article-title":"Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously","volume":"9","author":"Kelly","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0095","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI200524826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4161\/cc.3.6.927","article-title":"Histone-deacetylase inhibitors for the treatment of cancer","volume":"3","author":"Lindemann","year":"2004","journal-title":"Cell Cycle"},{"issue":"Suppl. 1","key":"10.1111\/j.0022-202X.2005.23925.x_bb0105","first-page":"S105","article-title":"Targeting BCL-2-related proteins in cancer therapy","volume":"2","author":"Manion","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4161\/cc.4.4.1564","article-title":"Histone deacetylase inhibitors in programmed cell death and cancer therapy","volume":"4","author":"Marks","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1471-4892(03)00084-5","article-title":"Histone deacetylases","volume":"3","author":"Marks","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2001.tb03710.x","article-title":"Reversible resistance to apoptosis in cutaneous T cell lymphoma","volume":"941","author":"Meech","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0125","first-page":"1509","article-title":"Role of histone deacetylase inhibitors in the treatment of cancer (Review)","volume":"25","author":"Mei","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2567.2005.02091.x","article-title":"Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas","volume":"114","author":"Mitchell","year":"2005","journal-title":"Immunology"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0135","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.0022-202X.2005.23657.x","article-title":"Resistance to activation-induced cell death and bystander cytotoxicity via the Fas\/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas","volume":"124","author":"Ni","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mjd.2001.108376","article-title":"Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy","volume":"44","author":"Osella-Aate","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0145","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2174\/1381612043383980","article-title":"A review of depsipeptide and other histone deacetylase inhibitors in clinical trials","volume":"10","author":"Piekarz","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0150","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1182\/blood-2003-09-3068","article-title":"T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: Impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance","volume":"103","author":"Piekarz","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.6600519","article-title":"Isolation and transmission of human retrovirus (HTLV)","volume":"219","author":"Popovic","year":"1983","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0165","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1128\/MCB.23.12.4162-4173.2003","article-title":"Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5","volume":"23","author":"Rascle","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0170","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.180316197","article-title":"Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation","volume":"97","author":"Richon","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0175","first-page":"30","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"2","author":"Rosato","year":"2003","journal-title":"Cancer Bio Ther"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0180","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0185","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ctrv.2004.04.006","article-title":"Histone deacetylase inhibitors\u2014a new tool to treat cancer","volume":"30","author":"Somech","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0190","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3","volume":"18","author":"Sommer","year":"2004","journal-title":"Leukemia"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.2910490218","article-title":"Establishment of an IL-2 independent human T-cell line possessing only the p70 IL-2 receptor","volume":"49","author":"Starkebaum","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0200","doi-asserted-by":"crossref","first-page":"13897","DOI":"10.1073\/pnas.94.25.13897","article-title":"Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins","volume":"94","author":"Takemoto","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.8.5.409","article-title":"STAT proteins as novel targets for cancer drug discovery","volume":"8","author":"Turkson","year":"2004","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0210","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1073\/pnas.0408732102","article-title":"Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors","volume":"102","author":"Ungerstedt","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1568009043481560","article-title":"Targeted histone deacetylase inhibition for cancer therapy","volume":"4","author":"Vigushin","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0220","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1038\/sj.onc.1203176","article-title":"Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2\/Bcl-XL, c-Jun, and p21CIP1, but independent of p53","volume":"18","author":"Vrana","year":"1999","journal-title":"Oncogene"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0225","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action","volume":"8","author":"Zhang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.1341","article-title":"Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells","volume":"200","author":"Zhang","year":"2003","journal-title":"J Pathol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0235","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.0022-202X.2004.23207.x","article-title":"The novel synthetic oleanane triterpenoid CDDO induces apoptosis in mycosis fungoides\/S\u00e9zary syndrome cells","volume":"123","author":"Zhang","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23925.x_bb0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1396-0296.2003.01646.x","article-title":"The treatment of cutaneous T-cell lymphoma with photopheresis","volume":"16","author":"Zic","year":"2003","journal-title":"Dermatol Ther"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15325057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15325057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T14:59:26Z","timestamp":1553612366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15325057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0022202X15325057"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2005.23925.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}